Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Obtainment of cell growth inhibiting polypeptide and its usage

A technology of polypeptide sequences and derivatives, which is applied in the field of medical bioengineering, can solve problems such as unclear mechanisms, and achieve the effect of improving the ability to inhibit the cell cycle

Inactive Publication Date: 2005-01-19
WUHAN YICHENG BIOTECH CO LTD
View PDF0 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

So far, a number of enzymes and proteins involved in Rb phosphorylation have been discovered, but because the Rb phosphorylation pathway is a very complex process involving multiple proteins, its mechanism is still unclear, and there is currently no effective method or compound that can Directly block the phosphorylation of Rb to inhibit cell growth

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Obtainment of cell growth inhibiting polypeptide and its usage
  • Obtainment of cell growth inhibiting polypeptide and its usage
  • Obtainment of cell growth inhibiting polypeptide and its usage

Examples

Experimental program
Comparison scheme
Effect test

example 1

[0016] Example 1: A polypeptide cDNA encoding the amino-terminal 25 amino acid residues of p55PIK was introduced into pEGFP plasmid (this polypeptide is hereinafter abbreviated as N25).

[0017] The pEGFP-N1 and pEGFP-C1 plasmid vectors were purchased from Clontech Company in the United States (catalogue numbers: 6085-1, 6084-1), and the plasmids contained cDNA encoding green fluorescent protein (GFP). , catalog numbers are: R6011, R6021) digested plasmids, and the digested plasmids were separated and purified in agarose gel for subsequent ligation reactions. The kit for recovering DNA fragments from the gel is from Qiagen, Germany (the catalog number is: 28704).

[0018] The cDNA encoding the full-length protein of mouse p55PIK was derived from the mouse testis tissue cDNA library (Stratagene, USA, catalog number: 937308), cloned into pcDNA3 (purchased from Invitrogen, catalog number: V79020), and used to amplify N25 The PCR primer sequences for cDNA are:

[0019] Primer 1:...

example 2

[0023] Example 2: Detection of DNA constructs expressing fusion proteins

[0024] The expression of the fusion protein was detected by conventional DNA transfection experiments. We used COS7 cells (purchased from ATCC, USA, catalog number: CRL-1651) to detect the expression of the fusion protein.

[0025] The transfection kit was purchased from Invitrogen (catalogue number 11668) in the United States, and the transfection experiment was also completed according to the instructions provided by the manufacturer. COS7 cells were cultured in DMEM nutrient solution with 10% calf serum. After 48 hours of transfection, the COS7 cells were washed twice with normal saline (PBS), the cells were lysed by adding cell lysate, and the DNA was destroyed by ultrasonic waves, then an appropriate amount of 2-mercaptoethanol and bromophenol blue were added, and treated in boiling water for 5 minutes. Stored on ice, then loaded on 12% SDS-polyacrylamide gel electrophoresis. The separated prote...

example 3

[0026] Example 3: An experiment in which the expression of N25 polypeptide inhibits cell growth and cell cycle.

[0027] Detected with NIH / 3T3 (mouse fibroblast epithelial cells, purchased from ATCC, USA, catalog number: CRL-1658) and MCF-7 (human breast cancer cell line, purchased from ATCC, USA, catalog number: HTB-22) Effect of N25 amino acid polypeptide on cell growth.

[0028] Cells were cultured in DMEM containing 10% fetal bovine serum (FBS) at 37°C, 5% CO 2 / 95% air culture conditions in 10 cm cell culture dish.

[0029] Plasmids used in experiments: pEGFP-N25 (expressing N25-GFP fusion protein); pEGFP-C25 (expressing GFP-N25 fusion protein); pEGFP-N1 or pEGFP-C1 as control plasmids.

[0030] Plasmids and liposome transfection reagents (purchased from Invitrogen, U.S., catalog number: 11668) for transfection were mixed, left at room temperature for 15 minutes, and added to cells cultured in serum-free DMEM nutrient solution (cell density approx. 50%) were cultured a...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a polypeptides making up of 25 amino acids, corresponding cDNA coded sequence, its preparation, the use of the peptide, its derivant and corresponding cDNA in treating tumor and other hyperplasia disease. The invention characterized in that it confirms that p55PIK protein with 25 amino acid in its amino end have key function in combining Rb, blocking Rb phosphorylation inside the cell, thus obtain a biological effect of inhibiting cell division. Making use of the peptide and transfecting corresponding cDNA and expressing the peptide inside the cell, can inhibit effectively cell growth and tumor growth. Meanwhile, the invention also discloses a novel method for blocking Rb phosphorylation process, and provides a novel method for manufacturing a tumor treating medicine.

Description

1. Technical field: [0001] The present invention relates to a kind of by 25 amino acids (methionine-aspartic acid-arginine-aspartic acid-aspartic acid-alanine-aspartic acid-tryptophan-arginine - Glutamic acid - Valine - Methionine - Methionine - Proline - Tyrosine - Serine - Threonine - Glutamic acid - Leucine - Isoleucine - Phenylalanine The application of the polypeptide composed of -tyrosine-isoleucine-glutamic acid-methionine) in the treatment of tumors and other proliferative diseases belongs to the field of medical bioengineering. 2. Background technology: [0002] Tumor is a disease that seriously endangers human health, and its mortality rate has become the second leading cause of death after cardiovascular and cerebrovascular diseases in China. Chemotherapy, radiotherapy and surgical treatment are mainly used in clinical practice. These methods have formed a relatively mature treatment system and achieved good results. However, due to the low selectivity of these ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K38/16A61P35/00C12N15/11
Inventor 夏献民程爱武胡俊波周剑峰
Owner WUHAN YICHENG BIOTECH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com